Imbio
Imbio is a Minneapolis-based medical imaging AI software company founded in 2005, developing diagnostic tools applied across radiology, cardiology, oncology, pathology, and neurology for healthcare providers. The company operates as a focused niche player in the broader AI diagnostics market.
- Company typePrivate
- Founded2005
- HeadquartersMinneapolis, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Imbio does
Imbio is a Minneapolis-based medical imaging software company founded in 2005 that develops AI-powered diagnostic tools for healthcare providers. The company's software applies artificial intelligence to medical imaging across five clinical specialties: radiology, cardiology, oncology, pathology, and neurology. Imbio is positioned in third-party market research as a key player in the AI diagnostics market, which is projected to grow from $2,680.3 million in 2026 to $10,416.2 million by 2033, and operates within the broader AI in MRI market projected to reach $9.54 billion by 2030.
The company's technology stack centers on AI algorithms applied to diagnostic imaging workflows, though specific model architectures, training data assets, and integration details are not publicly disclosed. Imbio competes alongside significantly larger and more capital-intensive vendors including GE Healthcare, Canon Medical Systems USA, Aidoc, Vuno, Alivecor, and Digital Diagnostics, but operates as a focused niche player with 11-50 employees and approximately $4.08 million in cumulative disclosed funding across three rounds (2013, 2015, and 2017, the last led by Invenshure).
Imbio's business model is not publicly disclosed, and no specific pricing structure, revenue figures, customer logos, distribution channels, or certifications/compliance details are available. The company is led by CEO David Hannes and Chairman Danny J. Cunagin. Imbio remains a private, for-profit entity headquartered in Minneapolis, Minnesota, and serves healthcare providers as its primary customer segment across multiple diagnostic use cases.
Imbio firmographics
Firmographics- Name
- Imbio
- Website
- https://imbio.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Imbio is a Minneapolis-based medical imaging AI software company founded in 2005, developing diagnostic tools applied across radiology, cardiology, oncology, pathology, and neurology for healthcare providers. The company operates as a focused niche player in the broader AI diagnostics market.
- Ownership category
- akta.pro rank
Imbio industry classification
Industry- Product category
- Medical Imaging AI Software
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)
- akta.pro secondary industries
- Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ), Medical Imaging AI (HDAAAEAH), AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG)
Keywords
Where Imbio is headquartered
LocationHeadquarters
- HQ city
- Minneapolis
- HQ country
- United States
- HQ region
- North America
Markets served
Imbio business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations
Imbio product offering
Product offeringCore offering
Imbio develops medical imaging software solutions that use artificial intelligence to deliver diagnostic capabilities across multiple clinical specialties. The company's offerings are designed to improve diagnostic accuracy and efficiency in medical imaging interpretation, serving healthcare providers in radiology, cardiology, oncology, pathology, and neurology.
Differentiator
Problem solved
Functional benefit
Companies that use Imbio
Customer profileSegments1 record
Ideal customer profiles1 record
Imbio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Imbio partnerships and signals
Strategic signalScale indicators2 records
Recent moves4 records
Expansion highlights3 records
Imbio competitors and assessment
Company assessmentBroad incumbents
- GE Healthcare: GE Healthcare is a global medical imaging equipment and software incumbent that increasingly embeds AI capabilities into its imaging platforms and Edison platform. It is comparable to Imbio as a large incumbent competing in AI diagnostics, though it offers imaging AI as part of a broader imaging equipment portfolio.
- Canon Medical Systems USA: Canon Medical Systems is a global imaging equipment vendor (CT, MRI, ultrasound) integrating AI into its modality platforms. It is comparable to Imbio as a broad incumbent competing in AI-enabled imaging diagnostics, with AI embedded into the imaging equipment stack rather than offered standalone.
Direct peers
- AliveCor: AliveCor builds AI-enabled cardiac diagnostics through ECG-based hardware and software. It is comparable to Imbio as a key player in the AI diagnostics market competing across cardiology use cases alongside Imbio's cardiology imaging AI capabilities.
- Viz.ai: Viz.ai is a healthcare AI company specializing in AI-powered care coordination and image analysis, particularly for stroke and other time-sensitive conditions. It is comparable to Imbio as a medical imaging AI vendor serving hospitals with FDA-cleared clinical decision-support software.
- Aidoc: Aidoc is a venture-backed clinical AI platform that deploys AI algorithms across CT imaging to triage and detect acute conditions. It is directly comparable to Imbio as a standalone radiology AI software vendor selling workflow-integrated decision-support tools to hospitals and imaging centers.
- Digital Diagnostics: Digital Diagnostics is an AI diagnostics company developing autonomous diagnostic systems, including in ophthalmology and dermatology. It is comparable to Imbio as an AI-driven clinical diagnostics software company competing in the same AI diagnostics market segment.
- HeartFlow: HeartFlow offers AI-enabled non-invasive cardiac diagnostics from CT imaging to assess coronary artery disease. It is comparable to Imbio as a specialty-focused AI imaging software company delivering clinical decision support to hospitals in cardiology and adjacent cardiovascular imaging.
- Arterys: Arterys provides cloud-based AI medical imaging analytics, including cardiac and oncology applications delivered through a SaaS platform. It is comparable to Imbio as a vendor of cloud-delivered AI imaging software serving radiology and cardiology specialists.
- Zebra Medical Vision (Nanox AI): Zebra Medical Vision, now operating as Nanox AI, develops AI algorithms for medical imaging interpretation across multiple modalities and pathologies. It competes directly with Imbio in multi-specialty radiology AI imaging analytics for healthcare providers.
Regional players
- VUNO: VUNO is a South Korea-based medical AI company developing diagnostic AI solutions across radiology, cardiology, and pathology. It is comparable to Imbio as a key player in the AI diagnostics market per industry analyst listings, though its primary geographic focus is Asia rather than the U.S.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights4 records
Customer concentration
Imbio social profiles
Digital presenceImbio financial estimates
Financial estimateRevenue estimate
Valuation estimate
Imbio leadership team
Management profileNumber of profiles
Profiles2 records
Imbio funding detail
Funding detailFunding overview
Funding rounds3 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Imbio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Imbio
What does Imbio do?
Imbio develops medical imaging software solutions that use artificial intelligence to deliver diagnostic capabilities across multiple clinical specialties. The company's offerings are designed to improve diagnostic accuracy and efficiency in medical imaging interpretation, serving healthcare providers in radiology, cardiology, oncology, pathology, and neurology.
When was Imbio founded?
Imbio was founded in 2005. It employs 11 to 50 people.
Where is Imbio based?
Imbio is headquartered in Minneapolis, United States, in the North America region.
Who are Imbio's main competitors?
Broad incumbents on record are GE Healthcare and Canon Medical Systems USA. Direct peers are AliveCor, Viz.ai, Aidoc, Digital Diagnostics, HeartFlow, Arterys and Zebra Medical Vision (Nanox AI). VUNO is listed as a regional player.
Does Imbio have an API?
No public API is recorded for Imbio.
What industry is Imbio in?
Imbio's product category is Medical Imaging AI Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software. Its NAICS code is 513210 and its SIC code is 7372.